Research Briefing | Apr 26, 2021

India | Worsening health conditions crystalise downside risks

Ipad Frame (30)

The rapidly swelling second wave has taken a big toll on the country’s health infrastructure. The health system has collapsed in the worst hit states, with even the national capital, Delhi, facing acute shortage of oxygen and Covid-19 hospital beds. While the official mortality rate has edged lower, it masks a rapidly rising death count. Deaths are now doubling every ten days (as opposed to an average of 29 days in the first wave) and even this figure is likely buttressed by delayed or under-reporting of deaths.

What you will learn from this report:

  • India’s escalating health burden, faltering vaccination rate, and lack of a convincing government strategy to contain the pandemic have prompted us to downgrade our 2021 GDP growth forecast to 10.2% from 11.8% previously.
  • GDP is expected to contract sequentially in Q2 and average 1.47% q/q sa in 2021. This is a notable downgrade from our pre-second wave average growth forecast of 1.64%, but represents a modest uptick from 1.44% in 2020.
  •  Notwithstanding the likelihood of further mobility restrictions, we expect India’s targeted lockdown approach, less stringent restrictions, and resilient consumer and business behaviour to mitigate the economic impact of the second wave.
Tags: ASEANCoronavirusCoronavirus vaccineCovid19Economic recoveryHealthcareIndiaInflationLockdown restrictionsSEA
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.